Impact of traditional ayurvedic drug Lipidom and Yoga Intervention vs Placebo in Dyslipidemia.
Phase 3
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseasesHealth Condition 2: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/11/046979
- Lead Sponsor
- Patanjali Research Institute governed by Patanjali Research Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Adult male and non-pregnant female population pre-diagnosed dyslipidemia.
2. Subject should have followed the level of TC, TG, LDL, HDL according to NCEP ATP III guideline. 3. BMI 20-30 kg/m2.
4. Subject willingness to participate and sign the informed consent form and ready to comply with protocol measures.
5. Subjects who can do yoga intervention.
Exclusion Criteria
1. Medical history of unstable angina.
2. Myocardial infarction.
3. I patients is having active cardiac, hepatic, renal disease or have history of stroke within past three months. If patients having active malignant condition.
4. Pregnant/Lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in laboratory parameters of lipid profile compared to baseline after 8 weeks of Ayurvedic intervention. <br/ ><br>Change in laboratory parameter of lipid profile compared to baseline after 3 months of yogic practices. <br/ ><br>Change in laboratory parameter of lipid profile compared to baseline after 3 months of placebo.Timepoint: Baseline, week 4 and week 8.
- Secondary Outcome Measures
Name Time Method Changes in the level of quality of life by HRQoL 36, depression, anxiety, stress levels by DASS, lifestyle modification by SLIQ, and fatigue by MFI questionnaire. <br/ ><br>Treatment satisfaction and adherence.Timepoint: Baseline, week 4 and week 8.